Weight-Loss Drugs Fuel Boom for Firms That Fill Syringes
Some contract drug manufacturers are investing billions of dollars to expand or build factories that fill the injection pens used to administer treatments like Novo Nordisk’s Wegovy.
Related Articles
Abuse of the Safety-Net 340B Drug Pricing Program: Why Should Physicians Care?
“What was once a program to uplift underserved communities now risks becoming a case study in how good intentions can go astray without accountability,” writes…
‘Chance Finding’ a True Breakthrough for Spinal Cord Injury?
Deep brain stimulation of the lateral hypothalamus improves walking and promotes recovery in patients with spinal cord injury, new research showed.
A Blueprint for Success in the Safe and Appropriate Prescribing of Opioid Analgesics
A Blueprint for Success in the Safe and Appropriate Prescribing of Opioid Analgesics: Do you know when to use opioid analgesic therapies? Check out these…
Clostridioides Difficile: Antimicrobial Prescribing
Antimicrobial prescribing strategy for managing C. difficile infection in adults, young people, and children
Rise in Psychotherapy Use Exposes Access Inequities
New data revealed an increase in outpatient psychotherapy use but highlighted disparities in access among less advantaged groups.
Muscle-Building Supplements May Lead Young Men to Steroids
Analysis revealed muscle-building supplement users had higher odds of initiating anabolic-androgenic steroid use by the next survey wave than nonusers.
Treating Pain Without Opioid Analgesics: The Right Patient at the Right Time
Do you know how to manage acute and chronic pain conditions with nonopioid analgesic treatments? Listen to our expert, Dr Steven Stanos, to learn more.
Chronic Kidney Disease: Assessment and Management
Covering the assessment and management of chronic kidney disease, including pharmacotherapy
Why Do People Struggle to Prioritize Their Long-Term Health?
Simply promoting “prevention is better than cure” doesn’t lead to the adoption of preventive behaviors. Here’s why.
Expert Discusses the ‘Four Pillars of Acne Pathogenesis’
“The average number of acne products used per patient is 2.53, but that’s also the average number of copays,” Shanna Miranti said.